## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ss-31-tendon`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ss-31-tendon/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-tendon/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-tendon/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ss-31-tendon/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-tendon/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ss-31-tendon/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ss-31-tendon` v2 · content_hash `38a6f14d8a29f6f5…` · thread_head genesis · 23 DIVs
- **thesis (c1):** Degenerative tenocytes from human rotator cuff tendons show increased depolarized mitochondria, reduced mitochondrial number and size, lower superoxide dismutase activity, upregulated MMP-1 and FABP4 genes, and decreased cell viability compared to healthy tenocytes.
  - c4 [human/active] No human clinical trials have tested SS-31 for tendon healing or tendinopathy.
  - c2 [preclinical/active] SS-31 treatment of degenerative human tenocytes reversed mitochondrial depolarization and morphology changes, increased superoxide dismutase activity, reduced M
  - c3 [preclinical/active] In a mouse supraspinatus tendinopathy model, SS-31 improved mitochondrial function and promoted tendon healing, with stronger effects when combined with subacro
  - c5 [anecdotal/active] Reddit discussions of SS-31 for tendons are sparse and indirect, with no detailed user reports of tendon-specific outcomes.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ss-31-tendon/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ss-31-tendon/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ss-31-tendon`
- **title:** SS-31 (Elamipretide) for Tendon Issues: Mitochondrial Repair Evidence
- **url:** https://miscsubjects.com/a/ss-31-tendon
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:08.729Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Tendon problems often involve degeneration where breakdown outruns repair. Tenocytes, the main cells in tendons, can develop mitochondrial dysfunction. This shows up as fewer and smaller mitochondria, depolarized membranes, lower antioxidant activity like superoxide dismutase, and shifts in gene expression tied to matrix remodeling and fatty infiltration. These changes link to reduced cell viability and slower healing in degenerative tendons.

If your tendons show chronic issues like rotator cuff problems or Achilles tendinopathy, mitochondrial stress in tenocytes may be one layer keeping repair behind degeneration.

## Why SS-31 (Elamipretide) might help you

SS-31 targets the inner mitochondrial membrane by binding cardiolipin. This stabilizes structure and supports energy production while cutting oxidative damage.

1. If mitochondrial number, size, or membrane potential is off in your tenocytes, SS-31 is discussed because it has been shown in lab work to restore those features.
2. If antioxidant defenses like superoxide dismutase are low, SS-31 is discussed because treatment raised activity in degenerative cells.
3. If gene patterns point to excess matrix breakdown or fat buildup, SS-31 is discussed because it lowered those markers in tested tenocytes.
4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

## How these fit together

Single-compound focus. SS-31 (Elamipretide) addresses the mitochondrial layer. If your profile includes other peptides, they would map to separate degeneration layers such as inflammation or collagen assembly.

## What the evidence actually shows

One in-vitro study used tenocytes from nine patients with degenerative supraspinatus tendons and nine healthy controls from hamstring biopsies. Degenerative cells showed more depolarized mitochondria, smaller and fewer mitochondria on electron microscopy, lower superoxide dismutase activity, higher MMP-1 and FABP4 gene expression, and reduced viability. SS-31 treatment reversed the mitochondrial depolarization and morphology changes, raised superoxide dismutase, lowered the upregulated genes, and gave a small viability boost (Zhang et al., 2022, Am J Sports Med).

A related murine study created supraspinatus tendinopathy in mice. SS-31 improved mitochondrial function and tendon healing metrics. Effects were stronger when combined with removal of subacromial impingement (Zhang et al., 2022, J Bone Joint Surg Am).

A 2022 poster described parallel in-vitro human tenocyte work and in-vivo mouse model results showing mitochondrial rescue and healing support.

No human clinical trials exist that test SS-31 specifically for tendon healing or tendinopathy. All tendon data are preclinical (human cells in culture or mouse models).

## What scientists say

Researchers conclude that mitochondrial dysfunction appears in degenerative tenocytes and that SS-31, as a mitochondrial protectant, could improve function and promote healing. They note it may be most useful alongside mechanical relief like impingement removal. The work positions mitochondrial protection as a potential new angle for tendinopathy treatment.

## What people say on Reddit

Discussions of SS-31 for tendons are rare and indirect. Some users mention it alongside other mitochondrial peptides when talking about chronic tendon issues or floxed tendons, usually in broader stacks for energy or recovery. Specific before-after tendon stories tied only to SS-31 are absent in public threads. Most peptide tendon talk centers on compounds like BPC-157 instead.

## What people say on X

Public posts on X about SS-31 and tendons are minimal. Occasional mentions link it to mitochondrial health in regenerative contexts, but no detailed user reports of tendon-specific outcomes appear in searchable discussions.

## What we do not know

Human dosing, timing, delivery method, and long-term effects for tendon applications remain unknown. Whether benefits seen in isolated cells or mice translate to living humans with tendon pain is untested. Interaction with physical therapy, surgery, or other peptides lacks data. Durability of any mitochondrial improvements after stopping treatment is unclear.

## Safety and limits

SS-31 has been tested in human trials for other conditions such as age-related macular degeneration and primary mitochondrial myopathy, where it showed good tolerability in short-term use. No dedicated safety data exist for tendon use. All tendon findings come from lab and animal settings, so real-world risk-benefit profile for this application is not established. It remains investigational.

## Claims (5)

- **c4** [human w=0.8] No human clinical trials have tested SS-31 for tendon healing or tendinopathy.
  - who_claims: grok/grok-4.3
  - sources: s1, s2
- **c1** [preclinical w=0.5] Degenerative tenocytes from human rotator cuff tendons show increased depolarized mitochondria, reduced mitochondrial number and size, lower superoxide dismutase activity, upregulated MMP-1 and FABP4 genes, and decreased cell viability compared to healthy tenocytes.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [preclinical w=0.5] SS-31 treatment of degenerative human tenocytes reversed mitochondrial depolarization and morphology changes, increased superoxide dismutase activity, reduced MMP-1 and FABP4 gene expression, and produced a small increase in cell viability.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c3** [preclinical w=0.5] In a mouse supraspinatus tendinopathy model, SS-31 improved mitochondrial function and promoted tendon healing, with stronger effects when combined with subacromial impingement removal.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c5** [anecdotal w=0.3] Reddit discussions of SS-31 for tendons are sparse and indirect, with no detailed user reports of tendon-specific outcomes.
  - who_claims: grok/grok-4.3
  - sources: s3

## Voxel graph (5 atoms · 11 edges)
- full graph: https://miscsubjects.com/api/articles/ss-31-tendon/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (3)
- chain valid: yes · head: `73914f140026787e`

### s1 · pubmed · ok
- title: Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model
- url: https://pubmed.ncbi.nlm.nih.gov/35862638/
- summary: In vitro study using human tenocytes from degenerative supraspinatus and healthy hamstring tendons; SS-31 reversed mitochondrial and gene expression changes.
- quote: There are changes in mitochondrial structure and function in tenocytes derived from degenerative tendons, and SS-31, as a mitochondrial protectant, could improve mitochondrial function and promote the healing of tendinopathy.
- claim_ids: c1, c2, c4
- hash: `5a392d8a65814a96`

### s2 · pubmed · ok
- title: SS-31 as a Mitochondrial Protectant in the Treatment of Tendinopathy: Evaluation in a Murine Supraspinatus Tendinopathy Model
- url: https://pubmed.ncbi.nlm.nih.gov/35984013/
- summary: Mouse model study showing SS-31 benefits on mitochondrial function and tendon healing metrics.
- quote: The mitochondrial protectant SS-31 improved mitochondrial function, promoting tendon healing, especially when combined with removal of subacromial impingement.
- claim_ids: c3, c4
- hash: `64d72715f000fdd6`

### s3 · reddit · ok
- title: Why Your Tendon Injury Isn't Healing
- url: https://www.reddit.com/r/Biohack_Blueprint/comments/1pbu4tr/why_your_tendon_injury_isnt_healing_and_what/
- summary: Indirect mention of SS-31 in a tendon healing discussion thread; no specific outcome reports.
- quote: some peptides to help with the healing could be NAD+, MOTS-C, SS-31 , plus CoQ10...
- claim_ids: c5
- hash: `73914f140026787e`

## Provenance (2 model passes)
- chain valid: yes · head: `f05d4b7ff09eb9cd`

- write · grok/grok-4.3 · 2026-06-29T23:45 · hash `791dc9526584`
- voxel_divide · owner · 2026-07-17T02:42 · hash `f05d4b7ff09e`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ss-31-tendon/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ss-31-tendon/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ss-31-tendon","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ss-31-tendon|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ss-31-tendon|tier|assertion`
- **iMessage ask:** `ss-31-tendon|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ss-31-tendon`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-tendon/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-tendon/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*